$76.99
+0.02 (+0.03%)
Open$76.97
Previous Close$76.97
Day High$77.00
Day Low$76.96
52W High$77.20
52W Low$10.30
Volume—
Avg Volume1.86M
Market Cap1.63B
P/E Ratio—
EPS$-4.60
SectorBiotechnology
Analyst Ratings
Hold
11 analysts
Price Target
-89.6% upside
Current
$76.99
$76.99
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 537.1K | 578.6K | 44.14M |
| Net Income | -100,067,546 | -97,016,903 | -12,888,213 |
| Profit Margin | -158,800.0% | -150,860.0% | -29.2% |
| EBITDA | -101,825,315 | -104,205,590 | -17,594,581 |
| Free Cash Flow | — | — | -11,802,396 |
| Rev Growth | -7.2% | -7.2% | -3.2% |
| Debt/Equity | — | — | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |